rs281875215, CARD14

N. diseases: 6
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
PSORIASIS 2
CUI: C1864497
Disease: PSORIASIS 2
0.800 GeneticVariation UNIPROT The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes. 27113748 2016
PSORIASIS 2
CUI: C1864497
Disease: PSORIASIS 2
0.800 GeneticVariation UNIPROT Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation. 27071417 2016
PSORIASIS 2
CUI: C1864497
Disease: PSORIASIS 2
0.800 GeneticVariation UNIPROT CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts. 26358359 2016
PSORIASIS 2
CUI: C1864497
Disease: PSORIASIS 2
0.800 GeneticVariation UNIPROT Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis. 22521419 2012
PSORIASIS 2
CUI: C1864497
Disease: PSORIASIS 2
0.800 GeneticVariation UNIPROT PSORS2 is due to mutations in CARD14. 22521418 2012
PSORIASIS 2
CUI: C1864497
Disease: PSORIASIS 2
0.800 CausalMutation CLINVAR
Pityriasis Rubra Pilaris
CUI: C0032027
Disease: Pityriasis Rubra Pilaris
0.700 GeneticVariation UNIPROT Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 Mutations. 27760266 2017
Pityriasis Rubra Pilaris
CUI: C0032027
Disease: Pityriasis Rubra Pilaris
0.700 GeneticVariation UNIPROT Familial pityriasis rubra pilaris is caused by mutations in CARD14. 22703878 2012
Psoriasis
CUI: C0033860
Disease: Psoriasis
0.030 GeneticVariation BEFREE Rare, highly penetrant, gain-of-function, dominantly acting mutations within the human caspase recruitment domain family, member 14 (CARD14) gene lead to the development of PS and psoriatic arthritis (PSA) (a familial p.G117S and de-novo p.E138A alteration). 31323190 2019
Psoriasis
CUI: C0033860
Disease: Psoriasis
0.030 GeneticVariation BEFREE In contrast with wild-type CARD14, CARD14(E138A) and CARD14(G117S) psoriasis mutants interacted constitutively with BCL10 and MALT1, and triggered BCL10- and MALT1-dependent activation of NF-κB in keratinocytes. 27071417 2016
Psoriasis
CUI: C0033860
Disease: Psoriasis
0.030 GeneticVariation BEFREE One family exhibiting suggestive evidence for linkage to 17q25 (PSORS2) was identified and all affected members harboured a p.Gly117Ser mutation in CARD14 (caspase recruitment domain family, member 14), recently reported to lead to psoriasis in a large family from the U.S.A. 23013406 2013
Salivary Gland Pleomorphic Adenoma
CUI: C1519176
Disease: Salivary Gland Pleomorphic Adenoma
0.010 GeneticVariation BEFREE Rare, highly penetrant, gain-of-function, dominantly acting mutations within the human caspase recruitment domain family, member 14 (CARD14) gene lead to the development of PS and psoriatic arthritis (PSA) (a familial p.G117S and de-novo p.E138A alteration). 31323190 2019
Arthritis, Psoriatic
CUI: C0003872
Disease: Arthritis, Psoriatic
0.010 GeneticVariation BEFREE Rare, highly penetrant, gain-of-function, dominantly acting mutations within the human caspase recruitment domain family, member 14 (CARD14) gene lead to the development of PS and psoriatic arthritis (PSA) (a familial p.G117S and de-novo p.E138A alteration). 31323190 2019
Familial psoriasis
CUI: C1304140
Disease: Familial psoriasis
0.010 GeneticVariation BEFREE The c.349G>A (p.Gly117Ser) familial-psoriasis mutation was present at a frequency of 0.0005 in cases of European ancestry. 22521419 2012